These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 23296464)

  • 1. The feasibilities of TruScreen for primary cervical cancer screening: a self-controlled study.
    Long S; Lei W; Feng Y; Lv D; Cai Y; Yang P
    Arch Gynecol Obstet; 2013 Jul; 288(1):113-8. PubMed ID: 23296464
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A real time optoelectronic device as an adjunct to the Pap smear for cervical screening: a multicenter evaluation.
    Singer A; Coppleson M; Canfell K; Skladnev V; Mackellar G; Pisal N; Deery A
    Int J Gynecol Cancer; 2003; 13(6):804-11. PubMed ID: 14675317
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical evaluation of a real-time optoelectronic device in cervical cancer screening.
    Wei Y; Wang W; Cheng M; Hong Z; Gu L; Niu J; Di W; Qiu L
    Eur J Obstet Gynecol Reprod Biol; 2021 Nov; 266():182-186. PubMed ID: 34625339
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of a real-time optoelectronic method in the diagnostics of CIN over four years of observations.
    Suchońska B; Gajzlerska-Majewska W; Wielgoś M
    PLoS One; 2021; 16(2):e0247702. PubMed ID: 33635909
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cytology versus HPV testing for cervical cancer screening in the general population.
    Koliopoulos G; Nyaga VN; Santesso N; Bryant A; Martin-Hirsch PP; Mustafa RA; Schünemann H; Paraskevaidis E; Arbyn M
    Cochrane Database Syst Rev; 2017 Aug; 8(8):CD008587. PubMed ID: 28796882
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Application of TruScreen in detecting ASCUS patients.
    Li W; Guo Y; Niu H; Jin S; Wang L
    Asian Pac J Trop Med; 2011 Aug; 4(8):669-71. PubMed ID: 21914550
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Determination of the diagnostic accuracy of testing for high-risk (HR) human papillomavirus (HPV) types 16, 18 and 45 in precancerous cervical lesions: preliminary data.
    Tiews S; Steinberg W; Schneider W; Hanrath C
    J Clin Virol; 2009 Nov; 46 Suppl 3():S11-5. PubMed ID: 20129068
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diagnostic Accuracy of Conventional Cell Blocks Along with p16INK4 and Ki67 Biomarkers as Triage Tests in Resource-poor Organized Cervical Cancer Screening Programs.
    Desai F; Singh LS; Majachunglu G; Kamei H
    Asian Pac J Cancer Prev; 2019 Mar; 20(3):917-923. PubMed ID: 30912415
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Verification of doubtful PAP smear results of women included in the screening program in the Podlaskie province].
    Błońska E; Knapp PA
    Ginekol Pol; 2013 Aug; 84(8):691-5. PubMed ID: 24191502
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Diagnostic value of TruScreen, cytology and colposcopy].
    Atanassova D; Zlatkov V; Borisov S; Veleva G
    Akush Ginekol (Sofiia); 2013; 52(3):7-18. PubMed ID: 24283057
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of conventional and liquid-based Pap smear methods in the diagnosis of precancerous cervical lesions.
    Honarvar Z; Zarisfi Z; Salari Sedigh S; Masoumi Shahrbabak M
    J Obstet Gynaecol; 2022 Aug; 42(6):2320-2324. PubMed ID: 35579303
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Age-specific evaluation of primary human papillomavirus screening vs conventional cytology in a randomized setting.
    Leinonen M; Nieminen P; Kotaniemi-Talonen L; Malila N; Tarkkanen J; Laurila P; Anttila A
    J Natl Cancer Inst; 2009 Dec; 101(23):1612-23. PubMed ID: 19903804
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of MN/CA9 protein in Papanicolaou smears containing atypical glandular cells of undetermined significance is a diagnostic biomarker of cervical dysplasia and neoplasia.
    Liao SY; Stanbridge EJ
    Cancer; 2000 Mar; 88(5):1108-21. PubMed ID: 10699902
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of liquid-based cytology with conventional cytology for detection of cervical cancer precursors: a randomized controlled trial.
    Siebers AG; Klinkhamer PJ; Grefte JM; Massuger LF; Vedder JE; Beijers-Broos A; Bulten J; Arbyn M
    JAMA; 2009 Oct; 302(16):1757-64. PubMed ID: 19861667
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Results of pap smears and immunocytochemical detection of the p16 and Ki67 proteins in women with cervical intraepithelial neoplasia and cervical cancer].
    Rokita W; Skawiński D; Zmelonek-Znamirowska A; Kedzia W; Karowicz-Bilińska A; Spaczyński R; Spaczyński M
    Ginekol Pol; 2012 Nov; 83(11):822-6. PubMed ID: 23379189
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A pilot study of HPV DNA and cytology testing in 50,159 women in the routine Mexican Social Security Program.
    Lazcano-Ponce E; Lörincz AT; Salmerón J; Fernández I; Cruz A; Hernández P; Mejia I; Hernández-Avila M
    Cancer Causes Control; 2010 Oct; 21(10):1693-700. PubMed ID: 20617376
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Clinical value of p16
    Song FB; Du H; Xiao AM; Wang C; Huang X; Yan PS; Liu ZH; Qu XF; Belinson JEROMEL; Wu RF
    Zhonghua Fu Chan Ke Za Zhi; 2020 Nov; 55(11):784-790. PubMed ID: 33228350
    [No Abstract]   [Full Text] [Related]  

  • 18. Do health care providers have a lower prevalence of abnormal pap smears than the general public?
    Suwannarurk K; Bhamarapravatana K; Kheolamai P; Thaweekul Y; Mairaing K; Poomtavorn Y; Pattaraarchachai J
    J Med Assoc Thai; 2010 Dec; 93 Suppl 7():S114-9. PubMed ID: 21294405
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A comparative study of cervical cancer screening methods in a rural community setting of North India.
    Satyanarayana L; Asthana S; Bhambani S; Sodhani P; Gupta S
    Indian J Cancer; 2014; 51(2):124-8. PubMed ID: 25104192
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cervical Screening by Pap Test and Visual Inspection Enabling Same-Day Biopsy in Low-Resource, High-Risk Communities.
    Tao L; Amanguli A; Li F; Wang YH; Yang L; Mohemaiti M; Zhao J; Zou XG; Saimaiti A; Abudu M; Maimaiti M; Chen SY; Abudukelimu R; Maimaiti A; Li SG; Zhang W; Aizimu A; Yang AQ; Wang J; Pang LJ; Cao YG; Gu WY; Zhang WJ
    Obstet Gynecol; 2018 Dec; 132(6):1421-1429. PubMed ID: 30399093
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.